Safety and Pharmacokinetics of Hyperimmune Anti-Human Immunodeficiency Virus (HIV) Immunoglobulin Administered to HIV-Infected Pregnant Women and Their Newborns
John S. Lambert(Mater Misericordiae University Hospital), Alice Stek(University of Southern California), Courtney V. Fletcher(University of Nebraska at Omaha), Edward H. O'Neill(University of Miami), William A. Meyer(Quest Diagnostics (United States)), Christine V. Sapan(University of Southern California), E. Richard Stiehm(European Respiratory Society), Jack Moye(National Institutes of Health), Lynne Mofenson(Elizabeth Glaser Pediatric AIDS Foundation), E. Jiménez(University of Maryland, Baltimore), Bonnie J. Mathieson(National Institute of Allergy and Infectious Diseases), Andrea Kovacs(University of Southern California), George J. Nemo(National Heart Lung and Blood Institute), G. Hirsch(University of Maryland, Baltimore), Larry M. Cummins(University of Maryland, Baltimore)
Cited by 63
Related Papers
Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus Type 1 with Zidovudine Treatment
|New England Journal of Medicine|1994|3.7k
Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial
|The Lancet|1999|1.7k
Liberal or Restrictive Transfusion in High-Risk Patients after Hip Surgery
|New England Journal of Medicine|2011|1.3k
Combination Antiretroviral Strategies for the Treatment of Pregnant HIV-1–Infected Women and Prevention of Perinatal HIV-1 Transmission
|JAIDS Journal of Acquired Immune Deficiency Syndromes|2002|896